Madrigal Pharmaceuticals

MDGL55

High Growth

$347.45arrow_drop_up5.48%$18.06

High Growth

MDGL55

$347.45

arrow_drop_up5.48%$18.06

High Growth

Performance History

Key Stats
Open	$323.72
Prev. Close	$329.24
EPS	-25.02
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	324.85	350.58
52 Week Range	119.76	368.73

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-25.02

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Madrigal Pharmaceuticals (MDGL)

Madrigal Pharmaceuticals Inc (MDGL) is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of cardiovascular and metabolic diseases. With a focus on liver-directed therapeutics, Madrigal is at the forefront of research and development in this field. The company's primary goal is to improve the lives of patients suffering from these chronic conditions.

MDGL stock price has shown a remarkable upward trend in recent years, reflecting the market's confidence in Madrigal's potential. The stock has experienced significant growth, outperforming industry peers and demonstrating strong investor interest. Investors have been particularly drawn to Madrigal's promising pipeline of drug candidates, which have shown promising results in preclinical and clinical trials.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Paul A. Friedman M.D.
Headquarters: West Conshohocken
Employees: 92
Exchange: NASDAQ

add Madrigal Pharmaceuticals to watchlist

Keep an eye on Madrigal Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Madrigal Pharmaceuticals 's (MDGL) price per share?

The current price per share for Madrigal Pharmaceuticals (MDGL) is $347.45. The stock has seen a price change of $18.07 recently, indicating a 5.49% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Madrigal Pharmaceuticals (MDGL)?

For Madrigal Pharmaceuticals (MDGL), the 52-week high is $368.74, which is 6.13% from the current price. The 52-week low is $119.76, the current price is 190.12% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Madrigal Pharmaceuticals (MDGL) a growth stock?

Madrigal Pharmaceuticals (MDGL) has shown an average price growth of -4.13% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Madrigal Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Madrigal Pharmaceuticals (MDGL) stock price performance year to date (YTD)?

As of the latest data, Madrigal Pharmaceuticals (MDGL) has a year-to-date price change of 53.16%. Over the past month, the stock has experienced a price change of 71.6%. Over the last three months, the change has been 37.47%. Over the past six months, the figure is 47.95%. Looking at a longer horizon, the five-year price change stands at 226.15%.

help

Is Madrigal Pharmaceuticals (MDGL) a profitable company?

Madrigal Pharmaceuticals (MDGL) has a net income of -$373.63M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -187.06% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$380.5M. Furthermore, the EBITDA is -$547.18M.

help

What is the market capitalization of Madrigal Pharmaceuticals (MDGL)?

Madrigal Pharmaceuticals (MDGL) has a market capitalization of $7.58B. The average daily trading volume is 344.42, indicating the stock's liquidity and investor engagement.

News

MADRIGAL PHARMACEUTICALS

1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More

MID-CAP STOCKS

GLOBALSTAR

V.F. CORP

MADRIGAL PHARMACEUTICALS

FINANCIAL RESULTS

BUSINESS UPDATES

Nov 3, 2024

Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?

This High-Flying Stock Just Became a Better Buy

MADRIGAL PHARMACEUTICALS